The Doris Duke Charitable Foundation has announced more than $13 million in grants through its Medical Research Program to support the career development of clinical researchers and increase the foundation's commitment to innovative research on sickle cell disease.
Twelve junior researchers will receive a total of $6 million in Clinical Scientist Development Awards (CSDA), which are designed to encourage young physician-scientists to remain committed to clinical research by providing them with support as they transition to an independent research career. Through the program, each grantee will receive $486,000 over three years to conduct research and establish a laboratory. The awardees are working in a variety of areas, including malaria, tuberculosis, and the clinical and economic benefits of the Medicaid Part D prescription drug program.
Through its Innovation in Clinical Research Award program, DDCF awarded seed funding for early stage, multi-disciplinary research projects in clinical investigation. Having awarded five ICRA grants last fall in an effort to reinvigorate funding and research collaborations targeting sickle cell disease, the foundation awarded three additional grants of $486,000 over three years for projects focused on the development of treatments or cures for the disease.
And to bolster the pipeline of physician-scientists, renewal grants totaling $6 million over four years were awarded to twelve leading academic medical centers participating in the foundation's Clinical Research Fellows program. CRF schools select at least five fellows annually to take a year off from their medical school training to participate in the program, which combines a mentored research project and coursework.
"We are pleased to be supporting the next generation of clinical researchers," said DDCF president Ed Henry. "Through the CRF and CSDA programs, we are encouraging more young people to enter research and providing the support that physician-scientists need as they make the critical shift to independent careers."